Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0000899243-22-026724

Chief Executive Officer sold 18,681 shares at $0.69 ($12,890)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Barrow Robert Chief Executive Officer 2022-07-25 Sale −18,681 $0.69 $12,890 3,880,788 D
Open-market sales · 18,681 sh · avg $0.69 · $12,890
Loading xslF345X03/doc4.xml…